Badr-Eldin, S.M.; Aldawsari, H.M.; Alhakamy, N.A.; Fahmy, U.A.; Ahmed, O.A.A.; Neamatallah, T.; Tima, S.; Almaghrabi, R.H.; Alkudsi, F.M.; Alamoudi, A.A.;
et al. Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells. Pharmaceutics 2022, 14, 1024.
https://doi.org/10.3390/pharmaceutics14051024
AMA Style
Badr-Eldin SM, Aldawsari HM, Alhakamy NA, Fahmy UA, Ahmed OAA, Neamatallah T, Tima S, Almaghrabi RH, Alkudsi FM, Alamoudi AA,
et al. Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells. Pharmaceutics. 2022; 14(5):1024.
https://doi.org/10.3390/pharmaceutics14051024
Chicago/Turabian Style
Badr-Eldin, Shaimaa M., Hibah M. Aldawsari, Nabil A. Alhakamy, Usama A. Fahmy, Osama A. A. Ahmed, Thikryat Neamatallah, Singkome Tima, Raghad H. Almaghrabi, Fayda M. Alkudsi, Asmaa A. Alamoudi,
and et al. 2022. "Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells" Pharmaceutics 14, no. 5: 1024.
https://doi.org/10.3390/pharmaceutics14051024
APA Style
Badr-Eldin, S. M., Aldawsari, H. M., Alhakamy, N. A., Fahmy, U. A., Ahmed, O. A. A., Neamatallah, T., Tima, S., Almaghrabi, R. H., Alkudsi, F. M., Alamoudi, A. A., Alzahrani, A. A., Kotta, S., & Al-hejaili, O. D.
(2022). Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells. Pharmaceutics, 14(5), 1024.
https://doi.org/10.3390/pharmaceutics14051024
